Chronic Quetiapine Administration Has a Therapeutic Effect on Anxiety and Depression‐Like Behavior in a Chronic Unpredictable Mild Stress (CUMS) Rat Model
Brain and Behavior · 2025
DOI: 10.1002/brb3.70755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Esra Komanovalı und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology, Institute of Science, Üsküdar University, İstanbul, Turkey. Hauptthemen laut MEDLINE: Quetiapine Fumarate, Stress, Psychological, Depression, Anxiety. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
The mechanisms underlying quetiapine's effects on anxiety‐ and depression‐like behaviors induced by chronic unpredictable mild stress (CUMS) remain unclear. This study aimed to evaluate the therapeutic potential of quetiapine in a rat model of CUMS. Materials and Methods In the first experiment, 40 adult female Wistar albino rats were randomly assigned to either a control group (non‐stressed, n = 20) or a chronic unpredictable mild stress (CUMS) group ( n = 20) for 28 consecutive days. To evaluate stress‐related behavioral changes, the sucrose preference test (SPT), fecal boli count, and elevated plus maze (EPM) test were conducted on days 29 and 30. In the second experiment, on day 30, animals from both initial groups were further divided into four experimental groups ( n = 10 per group): (1) Control (1 mL saline, i.p., for 30 days), (2) Quetiapine (QET; 10 mg/kg/day, i.p., for 30 days), (3) CUMS only (no treatment), and (4) CUMS + QET (10 mg/kg/day, i.p., for 30 days). Following treatment, behavioral assessments (SPT, forced swim test (FST), elevated plus maze test (EPM), and fecal boli count) were conducted on days 61, 62, and 63.
Results
CUMS induced significant anxiety‐ and depression‐like behaviors. Chronic quetiapine administration (10 mg/kg/day) reversed these behavioral deficits, suggesting antidepressant and anxiolytic effects.
Conclusion
Quetiapine alleviates CUMS‐induced anxiety and depression‐like behaviors, supporting its potential as both monotherapy and adjunctive treatment in stress‐related disorders. Further research should explore sex differences, dose‐response effects, biochemical or molecular markers, and other stress paradigms to optimize clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Biology, Institute of Science, Üsküdar University, İstanbul, Turkey.
- Department of Physiology, Faculty of Medicine, Üsküdar University, İstanbul, Turkey.
- Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Üsküdar University, Istanbul, Turkey.
ORCID-Profile: Burcu Çevreli, Öznur Özge Özcan
Zitieren
APA
Komanovalı, E., Çevreli, B., & Özcan, Ö. Ö. (2025). Chronic Quetiapine Administration Has a Therapeutic Effect on Anxiety and Depression‐Like Behavior in a Chronic Unpredictable Mild Stress (CUMS) Rat Model. Brain and Behavior. https://doi.org/10.1002/brb3.70755
Vancouver
Komanovalı E, Çevreli B, Özcan ÖÖ. Chronic Quetiapine Administration Has a Therapeutic Effect on Anxiety and Depression‐Like Behavior in a Chronic Unpredictable Mild Stress (CUMS) Rat Model. Brain and Behavior. 2025. doi:10.1002/brb3.70755
BibTeX
@article{Komanoval2025,
author = {Komanovalı, Esra and Çevreli, Burcu and Özcan, Öznur Özge},
title = {Chronic Quetiapine Administration Has a Therapeutic Effect on Anxiety and Depression‐Like Behavior in a Chronic Unpredictable Mild Stress (CUMS) Rat Model},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70755}
}
EUVIMED